{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:51:08Z","timestamp":1790758268239,"version":"4.1.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s11095-020-02891-z","type":"journal-article","created":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T18:25:14Z","timestamp":1598984714000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Impact of Reverse Micelle Loaded Lipid Nanocapsules on the Delivery of Gallic Acid into Activated Hepatic Stellate Cells: A Promising Therapeutic Approach for Hepatic Fibrosis"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6242-9545","authenticated-orcid":false,"given":"Shaimaa Ali Ali","family":"Radwan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walaa H.","family":"El-Maadawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliaa Nabil","family":"ElMeshad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raguia Aly","family":"Shoukri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Yousry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,1]]},"reference":[{"key":"2891_CR1","doi-asserted-by":"crossref","unstructured":"Shipley LC, Axley PD, Singal AK. Liver Fibrosis: A Clinical Update. Hepatology. 2019.","DOI":"10.33590\/emjhepatol\/10313576"},{"issue":"1","key":"2891_CR2","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1471-230X-10-40","volume":"10","author":"T Poynard","year":"2010","unstructured":"Poynard T, Lebray P, Ingiliz P, Varaut A, Varsat B, Ngo Y, et al. Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest). BMC Gastroenterol. 2010;10(1):40.","journal-title":"BMC Gastroenterol"},{"issue":"11","key":"2891_CR3","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1023\/A:1016268311867","volume":"12","author":"PP Constantinides","year":"1995","unstructured":"Constantinides PP. Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects. Pharm Res. 1995;12(11):1561\u201372.","journal-title":"Pharm Res"},{"key":"2891_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/7629724","volume":"2016","author":"R Bansal","year":"2016","unstructured":"Bansal R, Nag\u00f3rniewicz B, Prakash J. Clinical advancements in the targeted therapies against liver fibrosis. Mediat Inflamm. 2016;2016:1\u201316.","journal-title":"Mediat Inflamm"},{"key":"2891_CR5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3389\/fphar.2016.00033","volume":"7","author":"H-T Schon","year":"2016","unstructured":"Schon H-T, Bartneck M, Borkham-Kamphorst E, Nattermann J, Lammers T, Tacke F, et al. Pharmacological intervention in hepatic stellate cell activation and hepatic fibrosis. Front Pharmacol. 2016;7:33.","journal-title":"Front Pharmacol"},{"issue":"3","key":"2891_CR6","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1002\/hep.28948","volume":"65","author":"T Kisseleva","year":"2017","unstructured":"Kisseleva T. The origin of fibrogenic myofibroblasts in fibrotic liver. HEPATOLOGY. 2017;65(3):1039\u201343.","journal-title":"HEPATOLOGY."},{"key":"2891_CR7","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.jconrel.2017.09.035","volume":"266","author":"NS El-Mezayen","year":"2017","unstructured":"El-Mezayen NS, El-Hadidy WF, El-Refaie WM, Shalaby TI, Khattab MM, El-Khatib AS. Hepatic stellate cell-targeted imatinib nanomedicine versus conventional imatinib: a novel strategy with potent efficacy in experimental liver fibrosis. J Control Release. 2017;266:226\u201337.","journal-title":"J Control Release"},{"issue":"1","key":"2891_CR8","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00109-017-1593-6","volume":"96","author":"K Yu","year":"2018","unstructured":"Yu K, Li N, Cheng Q, Zheng J, Zhu M, Bao S, et al. miR-96-5p prevents hepatic stellate cell activation by inhibiting autophagy via ATG7. J Mol Med. 2018;96(1):65\u201374.","journal-title":"J Mol Med"},{"key":"2891_CR9","doi-asserted-by":"crossref","unstructured":"Yoon YJ, Friedman SL, Lee YA, editors. Antifibrotic therapies: where are we now? Seminars in liver disease: Thieme Medical Publishers; 2016.","DOI":"10.1055\/s-0036-1571295"},{"issue":"4","key":"2891_CR10","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.jhep.2014.05.047","volume":"61","author":"Y Iwakiri","year":"2014","unstructured":"Iwakiri Y, Shah V, Rockey DC. Vascular pathobiology in chronic liver disease and cirrhosis\u2013current status and future directions. J Hepatol. 2014;61(4):912\u201324.","journal-title":"J Hepatol"},{"issue":"5","key":"2891_CR11","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1002\/hep.27376","volume":"61","author":"LD DeLeve","year":"2015","unstructured":"DeLeve LD. Liver sinusoidal endothelial cells in hepatic fibrosis. HEPATOLOGY. 2015;61(5):1740\u20136.","journal-title":"HEPATOLOGY."},{"issue":"3","key":"2891_CR12","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1124\/jpet.118.256156","volume":"370","author":"Z Chen","year":"2019","unstructured":"Chen Z, Jain A, Liu H, Zhao Z, Cheng K. Targeted drug delivery to hepatic stellate cells for the treatment of liver fibrosis. J Pharmacol Exp Ther. 2019;370(3):695\u2013702.","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"2891_CR13","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1080\/10837450.2017.1344994","volume":"23","author":"EM Abdou","year":"2018","unstructured":"Abdou EM, Masoud MM. Gallic acid\u2013PAMAM and gallic acid\u2013phospholipid conjugates, physicochemical characterization and in vivo evaluation. Pharm Dev Technol. 2018;23(1):55\u201366.","journal-title":"Pharm Dev Technol"},{"issue":"9","key":"2891_CR14","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1007\/s11095-009-9926-y","volume":"26","author":"M Kaur","year":"2009","unstructured":"Kaur M, Velmurugan B, Rajamanickam S, Agarwal R, Agarwal C. Gallic acid, an active constituent of grape seed extract, exhibits anti-proliferative, pro-apoptotic and anti-tumorigenic effects against prostate carcinoma xenograft growth in nude mice. Pharm Res. 2009;26(9):2133\u201340.","journal-title":"Pharm Res"},{"issue":"6","key":"2891_CR15","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1248\/bpb.30.1052","volume":"30","author":"Y-J Kim","year":"2007","unstructured":"Kim Y-J. Antimelanogenic and antioxidant properties of gallic acid. Biol Pharm Bull. 2007;30(6):1052\u20135.","journal-title":"Biol Pharm Bull"},{"issue":"3","key":"2891_CR16","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.3390\/molecules18032483","volume":"18","author":"KY Liu","year":"2013","unstructured":"Liu KY, Hu S, Chan BC, Wat EC, Lau C, Hon KL, et al. Anti-inflammatory and anti-allergic activities of Pentaherb formula, Moutan cortex (Danpi) and gallic acid. Molecules. 2013;18(3):2483\u2013500.","journal-title":"Molecules."},{"issue":"3","key":"2891_CR17","first-page":"605","volume":"30","author":"A Faried","year":"2007","unstructured":"Faried A, Kurnia D, Faried L, Usman N, Miyazaki T, Kato H, et al. Anticancer effects of gallic acid isolated from Indonesian herbal medicine, Phaleria macrocarpa (Scheff.) Boerl, on human cancer cell lines. Int J Oncol. 2007;30(3):605\u201313.","journal-title":"Int J Oncol"},{"issue":"1","key":"2891_CR18","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jtcme.2018.01.010","volume":"9","author":"NM El-Lakkany","year":"2019","unstructured":"El-Lakkany NM, El-Maadawy WH, SHS E-d, Saleh S, Safar MM, Ezzat SM, et al. Antifibrotic effects of gallic acid on hepatic stellate cells: in vitro and in vivo mechanistic study. J Tradit Complement Med. 2019;9(1):45\u201353.","journal-title":"J Tradit Complement Med"},{"issue":"6","key":"2891_CR19","first-page":"525","volume":"41","author":"Z Sourani","year":"2016","unstructured":"Sourani Z, Pourgheysari B, Beshkar P, Shirzad H, Shirzad M. Gallic acid inhibits proliferation and induces apoptosis in lymphoblastic leukemia cell line (C121). Iranian journal of medical sciences. 2016;41(6):525.","journal-title":"Iranian journal of medical sciences"},{"issue":"1","key":"2891_CR20","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3892\/ol.2015.3845","volume":"11","author":"G Sun","year":"2016","unstructured":"Sun G, Zhang S, Xie Y, Zhang Z, Zhao W. Gallic acid as a selective anticancer agent that induces apoptosis in SMMC-7721 human hepatocellular carcinoma cells. Oncol Lett. 2016;11(1):150\u20138.","journal-title":"Oncol Lett"},{"issue":"5","key":"2891_CR21","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.1021\/acs.chemrev.5b00148","volume":"116","author":"G Chen","year":"2016","unstructured":"Chen G, Roy I, Yang C, Prasad PN. Nanochemistry and nanomedicine for nanoparticle-based diagnostics and therapy. Chem Rev. 2016;116(5):2826\u201385.","journal-title":"Chem Rev"},{"key":"2891_CR22","doi-asserted-by":"publisher","first-page":"119616","DOI":"10.1016\/j.biomaterials.2019.119616","volume":"230","author":"Q-Q Fan","year":"2020","unstructured":"Fan Q-Q, Zhang C-L, Qiao J-B, Cui P-F, Xing L, Oh Y-K, et al. Extracellular matrix-penetrating nanodrill micelles for liver fibrosis therapy. Biomaterials. 2020;230:119616.","journal-title":"Biomaterials."},{"issue":"10","key":"2891_CR23","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.3390\/cells8101279","volume":"8","author":"K Levada","year":"2019","unstructured":"Levada K, Omelyanchik A, Rodionova V, Weiskirchen R, Bartneck M. Magnetic-assisted treatment of liver fibrosis. Cells. 2019;8(10):1279.","journal-title":"Cells."},{"issue":"5","key":"2891_CR24","doi-asserted-by":"publisher","first-page":"645","DOI":"10.4155\/tde.12.38","volume":"3","author":"C Heneweer","year":"2012","unstructured":"Heneweer C, Gendy SE, Pe\u00f1ate-Medina O. Liposomes and inorganic nanoparticles for drug delivery and cancer imaging. Ther Deliv. 2012;3(5):645\u201356.","journal-title":"Ther Deliv"},{"key":"2891_CR25","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ejpb.2018.11.018","volume":"134","author":"R Hassan","year":"2019","unstructured":"Hassan R, Tammam SN, El Safy S, Abdel-Halim M, Asimakopoulou A, Weiskirchen R, et al. Prevention of hepatic stellate cell activation using JQ1-and atorvastatin-loaded chitosan nanoparticles as a promising approach in therapy of liver fibrosis. Eur J Pharm Biopharm. 2019;134:96\u2013106.","journal-title":"Eur J Pharm Biopharm"},{"issue":"6","key":"2891_CR26","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1023\/A:1016121319668","volume":"19","author":"B Heurtault","year":"2002","unstructured":"Heurtault B, Saulnier P, Pech B, Proust J-E, Benoit J-P. A novel phase inversion-based process for the preparation of lipid nanocarriers. Pharm Res. 2002;19(6):875\u201380.","journal-title":"Pharm Res"},{"key":"2891_CR27","doi-asserted-by":"publisher","first-page":"7565","DOI":"10.2147\/IJN.S180040","volume":"13","author":"A-C Groo","year":"2018","unstructured":"Groo A-C, Matougui N, Umerska A, Saulnier P. Reverse micelle-lipid nanocapsules: a novel strategy for drug delivery of the plectasin derivate AP138 antimicrobial peptide. Int J Nanomedicine. 2018;13:7565\u201374.","journal-title":"Int J Nanomedicine"},{"issue":"2","key":"2891_CR28","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ijpharm.2009.04.026","volume":"379","author":"NT Huynh","year":"2009","unstructured":"Huynh NT, Passirani C, Saulnier P, Beno\u00eet J-P. Lipid nanocapsules: a new platform for nanomedicine. Int J Pharm. 2009;379(2):201\u20139.","journal-title":"Int J Pharm"},{"issue":"5","key":"2891_CR29","first-page":"691","volume":"7","author":"S Movassaghian","year":"2015","unstructured":"Movassaghian S, Merkel OM, Torchilin VP. Applications of polymer micelles for imaging and drug delivery. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology. 2015;7(5):691\u2013707.","journal-title":"Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology"},{"issue":"2","key":"2891_CR30","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.ijpharm.2009.05.031","volume":"379","author":"E Allard","year":"2009","unstructured":"Allard E, Huynh NT, Vessieres A, Pigeon P, Jaouen G, Benoit J-P, et al. Dose effect activity of ferrocifen-loaded lipid nanocapsules on a 9L-glioma model. Int J Pharm. 2009;379(2):317\u201323.","journal-title":"Int J Pharm"},{"issue":"2","key":"2891_CR31","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.ijpharm.2004.03.018","volume":"278","author":"A Lamprecht","year":"2004","unstructured":"Lamprecht A, Saumet J-L, Roux J, Benoit J-P. Lipid nanocarriers as drug delivery system for ibuprofen in pain treatment. Int J Pharm. 2004;278(2):407\u201314.","journal-title":"Int J Pharm"},{"key":"2891_CR32","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.msec.2015.11.014","volume":"60","author":"ACS Alves","year":"2016","unstructured":"Alves ACS, Mainardes RM, Khalil NM. Nanoencapsulation of gallic acid and evaluation of its cytotoxicity and antioxidant activity. Mater Sci Eng C. 2016;60:126\u201334.","journal-title":"Mater Sci Eng C"},{"issue":"1\u20132","key":"2891_CR33","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.ijpharm.2010.07.039","volume":"398","author":"N Anton","year":"2010","unstructured":"Anton N, Mojzisova H, Porcher E, Benoit J-P, Saulnier P. Reverse micelle-loaded lipid nano-emulsions: new technology for nano-encapsulation of hydrophilic materials. Int J Pharm. 2010;398(1\u20132):204\u20139.","journal-title":"Int J Pharm"},{"issue":"1","key":"2891_CR34","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.ejpb.2011.02.015","volume":"79","author":"S Vrignaud","year":"2011","unstructured":"Vrignaud S, Anton N, Gayet P, Benoit J-P, Saulnier P. Reverse micelle-loaded lipid nanocarriers: a novel drug delivery system for the sustained release of doxorubicin hydrochloride. Eur J Pharm Biopharm. 2011;79(1):197\u2013204.","journal-title":"Eur J Pharm Biopharm"},{"issue":"1\u20132","key":"2891_CR35","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.ijpharm.2018.09.034","volume":"551","author":"Y Montigaud","year":"2018","unstructured":"Montigaud Y, Ucakar B, Krishnamachary B, Bhujwalla ZM, Feron O, Pr\u00e9at V, et al. Optimized acriflavine-loaded lipid nanocapsules as a safe and effective delivery system to treat breast cancer. Int J Pharm. 2018;551(1\u20132):322\u20138.","journal-title":"Int J Pharm"},{"issue":"1\u20132","key":"2891_CR36","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.ijpharm.2012.06.026","volume":"436","author":"S Vrignaud","year":"2012","unstructured":"Vrignaud S, Hureaux J, Wack S, Benoit J-P, Saulnier P. Design, optimization and in vitro evaluation of reverse micelle-loaded lipid nanocarriers containing erlotinib hydrochloride. Int J Pharm. 2012;436(1\u20132):194\u2013200.","journal-title":"Int J Pharm"},{"issue":"1\u20132","key":"2891_CR37","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.ijpharm.2015.03.020","volume":"485","author":"AA Abdelbary","year":"2015","unstructured":"Abdelbary AA, AbouGhaly MH. Design and optimization of topical methotrexate loaded niosomes for enhanced management of psoriasis: application of box\u2013Behnken design, in-vitro evaluation and in-vivo skin deposition study. Int J Pharm. 2015;485(1\u20132):235\u201343.","journal-title":"Int J Pharm"},{"issue":"1","key":"2891_CR38","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.ijpharm.2013.07.031","volume":"454","author":"H Chaudhary","year":"2013","unstructured":"Chaudhary H, Kohli K, Kumar V. Nano-transfersomes as a novel carrier for transdermal delivery. Int J Pharm. 2013;454(1):367\u201380.","journal-title":"Int J Pharm"},{"issue":"8","key":"2891_CR39","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1080\/03639045.2017.1318899","volume":"43","author":"SAA Radwan","year":"2017","unstructured":"Radwan SAA, ElMeshad AN, Shoukri RA. Microemulsion loaded hydrogel as a promising vehicle for dermal delivery of the antifungal sertaconazole: design, optimization and ex vivo evaluation. Drug Dev Ind Pharm. 2017;43(8):1351\u201365.","journal-title":"Drug Dev Ind Pharm"},{"issue":"3","key":"2891_CR40","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1080\/10408347.2015.1095064","volume":"46","author":"FHA Fernandes","year":"2016","unstructured":"Fernandes FHA, Salgado HRN. Gallic acid: review of the methods of determination and quantification. Crit Rev Anal Chem. 2016;46(3):257\u201365.","journal-title":"Crit Rev Anal Chem"},{"issue":"3","key":"2891_CR41","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1007\/s11051-014-2285-6","volume":"16","author":"L Rashidi","year":"2014","unstructured":"Rashidi L, Vasheghani-Farahani E, Soleimani M, Atashi A, Rostami K, Gangi F, et al. A cellular uptake and cytotoxicity properties study of gallic acid-loaded mesoporous silica nanoparticles on Caco-2 cells. J Nanopart Res. 2014;16(3):2285.","journal-title":"J Nanopart Res"},{"issue":"5","key":"2891_CR42","first-page":"170","volume":"6","author":"IK Pathan","year":"2013","unstructured":"Pathan IK, Patel RK, Bhandari A. Standardization development and validation of spectrophotometric method for simultaneous estimation of embelin and gallic acid as individual and in combination in ayurvedic churna formulation. Asian journal of pharmaceutical and clinical research. 2013;6(5):170\u20135.","journal-title":"Asian journal of pharmaceutical and clinical research"},{"issue":"5","key":"2891_CR43","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1166\/jbns.2015.1324","volume":"9","author":"AG Patil","year":"2015","unstructured":"Patil AG, Jobanputra AH. Formulation, characterization and evaluation of a Thermoresponsive in situ gel containing Gallic acid-loaded chitosan nanoparticles for the treatment of periodontal disease. Journal of Bionanoscience. 2015;9(5):401\u20138.","journal-title":"Journal of Bionanoscience"},{"key":"2891_CR44","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.ijbiomac.2013.11.041","volume":"64","author":"SM Abdel-Hafez","year":"2014","unstructured":"Abdel-Hafez SM, Hathout RM, Sammour OA. Towards better modeling of chitosan nanoparticles production: screening different factors and comparing two experimental designs. Int J Biol Macromol. 2014;64:334\u201340.","journal-title":"Int J Biol Macromol"},{"key":"2891_CR45","doi-asserted-by":"crossref","unstructured":"Mehta DM, Dave DJ, Dadhaniya DV, Shelat PK, Parejiya PB, Barot BS. Application of Box-Behnken design to formulate and optimize multipolymeric fast dissolving film of rizatriptan benzoate. Asian Journal of Pharmaceutics. 2014;8(1).","DOI":"10.4103\/0973-8398.134098"},{"issue":"1","key":"2891_CR46","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40199-014-0087-0","volume":"23","author":"B Gajra","year":"2015","unstructured":"Gajra B, Dalwadi C, Patel R. Formulation and optimization of itraconazole polymeric lipid hybrid nanoparticles (Lipomer) using box behnken design. DARU Journal of Pharmaceutical Sciences. 2015;23(1):3.","journal-title":"DARU Journal of Pharmaceutical Sciences"},{"issue":"1\u20132","key":"2891_CR47","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.ijpharm.2012.12.049","volume":"443","author":"SA Tayel","year":"2013","unstructured":"Tayel SA, El-Nabarawi MA, Tadros MI, Abd-Elsalam WH. Promising ion-sensitive in situ ocular nanoemulsion gels of terbinafine hydrochloride: design, in vitro characterization and in vivo estimation of the ocular irritation and drug pharmacokinetics in the aqueous humor of rabbits. Int J Pharm. 2013;443(1\u20132):293\u2013305.","journal-title":"Int J Pharm"},{"key":"2891_CR48","doi-asserted-by":"crossref","unstructured":"Boseila AA, Abdel-Reheem AY, Basalious EB. Design of bile-based vesicles (BBVs) for hepatocytes specific delivery of Daclatasvir: Comparison of ex-vivo transenterocytic transport, in-vitro protein adsorption resistance and HepG2 cellular uptake of charged and \u03b2-sitosterol decorated vesicles. PloS one. 2019;14((7)).","DOI":"10.1371\/journal.pone.0219752"},{"key":"2891_CR49","first-page":"e3917","volume":"64","author":"L Shen","year":"2012","unstructured":"Shen L, Hillebrand A, Wang DQ-H, Liu M. Isolation and primary culture of rat hepatic cells. JoVE. Journal of Visualized Experiments. 2012;64:e3917.","journal-title":"Journal of Visualized Experiments"},{"issue":"3","key":"2891_CR50","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1038\/nprot.2006.179","volume":"1","author":"V Vichai","year":"2006","unstructured":"Vichai V, Kirtikara K. Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat Protoc. 2006;1(3):1112\u20136.","journal-title":"Nat Protoc"},{"issue":"5","key":"2891_CR51","first-page":"37","volume":"3","author":"K Kardani","year":"2013","unstructured":"Kardani K, Gurav N, Solanki B, Patel P, Patel B. RP-HPLC method development and validation of gallic acid in polyherbal tablet formulation. Journal of Applied Pharmaceutical Science. 2013;3(5):37.","journal-title":"Journal of Applied Pharmaceutical Science"},{"issue":"23","key":"2891_CR52","doi-asserted-by":"publisher","first-page":"7242","DOI":"10.3748\/wjg.v20.i23.7242","volume":"20","author":"L Giannitrapani","year":"2014","unstructured":"Giannitrapani L, Soresi M, Bond\u00ec ML, Montalto G, Cervello M. Nanotechnology applications for the therapy of liver fibrosis. World J Gastroenterol: WJG. 2014;20(23):7242\u201351.","journal-title":"World J Gastroenterol: WJG"},{"key":"2891_CR53","doi-asserted-by":"publisher","first-page":"6997","DOI":"10.2147\/IJN.S145951","volume":"12","author":"SP Surendran","year":"2017","unstructured":"Surendran SP, Thomas RG, Moon MJ, Jeong YY. Nanoparticles for the treatment of liver fibrosis. Int J Nanomedicine. 2017;12:6997\u20137006.","journal-title":"Int J Nanomedicine"},{"issue":"7","key":"2891_CR54","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1248\/bpb.29.1521","volume":"29","author":"Y Higuchi","year":"2006","unstructured":"Higuchi Y, Kawakami S, Fumoto S, Yamashita F, Hashida M. Effect of the particle size of galactosylated lipoplex on hepatocyte-selective gene transfection after intraportal administration. Biol Pharm Bull. 2006;29(7):1521\u20133.","journal-title":"Biol Pharm Bull"},{"issue":"8","key":"2891_CR55","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/nrd2591","volume":"9","author":"RA Petros","year":"2010","unstructured":"Petros RA, DeSimone JM. Strategies in the design of nanoparticles for therapeutic applications. Nat Rev Drug Discov. 2010;9(8):615\u201327.","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"2891_CR56","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1166\/jbn.2014.1715","volume":"10","author":"G Tiram","year":"2014","unstructured":"Tiram G, Scomparin A, Ofek P, Satchi-Fainaro R. Interfering cancer with polymeric siRNA nanomedicines. J Biomed Nanotechnol. 2014;10(1):50\u201366.","journal-title":"J Biomed Nanotechnol"},{"issue":"3","key":"2891_CR57","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s11095-009-0024-y","volume":"27","author":"J Hureaux","year":"2010","unstructured":"Hureaux J, Lagarce F, Gagnadoux F, Rousselet M-C, Moal V, Urban T, et al. Toxicological study and efficacy of blank and paclitaxel-loaded lipid nanocapsules after iv administration in mice. Pharm Res. 2010;27(3):421\u201330.","journal-title":"Pharm Res"},{"issue":"14","key":"2891_CR58","doi-asserted-by":"publisher","first-page":"3651","DOI":"10.1021\/jp0664768","volume":"111","author":"N Anton","year":"2007","unstructured":"Anton N, Saulnier P, Beduneau A, Benoit J-P. Salting-out effect induced by temperature cycling on a water\/nonionic surfactant\/oil system. J Phys Chem B. 2007;111(14):3651\u20137.","journal-title":"J Phys Chem B"},{"issue":"4","key":"2891_CR59","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.colsurfb.2005.07.001","volume":"44","author":"I Minkov","year":"2005","unstructured":"Minkov I, Ivanova T, Panaiotov I, Proust J, Saulnier P. Reorganization of lipid nanocapsules at air\u2013water interface: part 2. Properties of the formed surface film. Colloids Surf B: Biointerfaces. 2005;44(4):197\u2013203.","journal-title":"Colloids Surf B: Biointerfaces"},{"issue":"2","key":"2891_CR60","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jconrel.2005.06.006","volume":"107","author":"K Manjunath","year":"2005","unstructured":"Manjunath K, Venkateswarlu V. Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administration. J Control Release. 2005;107(2):215\u201328.","journal-title":"J Control Release"},{"issue":"2","key":"2891_CR61","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.jconrel.2011.12.023","volume":"159","author":"F Li","year":"2012","unstructured":"Li F, Li Q-H, Wang J-Y, Zhan C-Y, Xie C, Lu W-Y. Effects of interferon-gamma liposomes targeted to platelet-derived growth factor receptor\u2013beta on hepatic fibrosis in rats. J Control Release. 2012;159(2):261\u201370.","journal-title":"J Control Release"},{"key":"2891_CR62","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.ejps.2013.11.017","volume":"52","author":"J Yang","year":"2014","unstructured":"Yang J, Hou Y, Ji G, Song Z, Liu Y, Dai G, et al. Targeted delivery of the RGD-labeled biodegradable polymersomes loaded with the hydrophilic drug oxymatrine on cultured hepatic stellate cells and liver fibrosis in rats. Eur J Pharm Sci. 2014;52:180\u201390.","journal-title":"Eur J Pharm Sci"},{"key":"2891_CR63","doi-asserted-by":"crossref","unstructured":"Adrian JE, Kamps JA, Scherphof GL, Meijer DK, Reker-Smit C, Terpstra P, et al. A novel lipid-based drug carrier targeted to the non-parenchymal cells, including hepatic stellate cells, in the fibrotic livers of bile duct ligated rats. Biochimica et Biophysica Acta (BBA)-Biomembranes. 2007;1768(6):1430\u20131439.","DOI":"10.1016\/j.bbamem.2007.03.027"},{"issue":"7","key":"2891_CR64","doi-asserted-by":"publisher","first-page":"3097","DOI":"10.1208\/s12249-018-1138-5","volume":"19","author":"MA Naseef","year":"2018","unstructured":"Naseef MA, Ibrahim HK, Nour SAE-K. Solid form of lipid-based self-nanoemulsifying drug delivery systems for minimization of diacerein adverse effects: development and bioequivalence evaluation in albino rabbits. AAPS PharmSciTech. 2018;19(7):3097\u2013109.","journal-title":"AAPS PharmSciTech"},{"issue":"9","key":"2891_CR65","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1007\/s10856-013-4965-7","volume":"24","author":"CV Pardeshi","year":"2013","unstructured":"Pardeshi CV, Belgamwar VS, Tekade AR, Surana SJ. Novel surface modified polymer\u2013lipid hybrid nanoparticles as intranasal carriers for ropinirole hydrochloride: in vitro, ex vivo and in vivo pharmacodynamic evaluation. J Mater Sci Mater Med. 2013;24(9):2101\u201315.","journal-title":"J Mater Sci Mater Med"},{"issue":"1\u20132","key":"2891_CR66","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s10847-014-0449-8","volume":"81","author":"E Pinho","year":"2015","unstructured":"Pinho E, Soares G, Henriques M. Cyclodextrin modulation of gallic acid in vitro antibacterial activity. J Incl Phenom Macrocycl Chem. 2015;81(1\u20132):205\u201314.","journal-title":"J Incl Phenom Macrocycl Chem"},{"key":"2891_CR67","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.chemosphere.2013.10.093","volume":"99","author":"Y Du","year":"2014","unstructured":"Du Y, Chen H, Zhang Y, Chang Y. Photodegradation of gallic acid under UV irradiation: insights regarding the pH effect on direct photolysis and the ROS oxidation-sensitized process of DOM. Chemosphere. 2014;99:254\u201360.","journal-title":"Chemosphere."},{"key":"2891_CR68","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejps.2018.05.016","volume":"121","author":"D Abozaid","year":"2018","unstructured":"Abozaid D, Ramadan A, Barakat H, Khalafallah N. Acyclovir lipid nanocapsules gel for oromucosal delivery: a preclinical evidence of efficacy in the chicken pouch membrane model. Eur J Pharm Sci. 2018;121:228\u201335.","journal-title":"Eur J Pharm Sci"},{"issue":"19","key":"2891_CR69","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1002\/smll.201402870","volume":"11","author":"HT Duong","year":"2015","unstructured":"Duong HT, Dong Z, Su L, Boyer C, George J, Davis TP, et al. The use of nanoparticles to deliver nitric oxide to hepatic stellate cells for treating liver fibrosis and portal hypertension. Small. 2015;11(19):2291\u2013304.","journal-title":"Small."},{"issue":"2","key":"2891_CR70","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1111\/j.1572-0241.2005.40952.x","volume":"100","author":"A C\u00e1rdenas","year":"2005","unstructured":"C\u00e1rdenas A. Hepatorenal syndrome: a dreaded complication of end-stage liver disease. Am J Gastroenterol. 2005;100(2):460\u20137.","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"2891_CR71","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1080\/10286020.2017.1384819","volume":"20","author":"H Ghaznavi","year":"2018","unstructured":"Ghaznavi H, Fatemi I, Kalantari H, Hosseini Tabatabaei SMT, Mehrabani M, Gholamine B, et al. Ameliorative effects of gallic acid on gentamicin-induced nephrotoxicity in rats. J Asian Nat Prod Res. 2018;20(12):1182\u201393.","journal-title":"J Asian Nat Prod Res"},{"key":"2891_CR72","doi-asserted-by":"crossref","unstructured":"Asci H, Ozmen O, Ellidag HY, Aydin B, Bas E, Yilmaz N. The impact of gallic acid on the methotrexate-induced kidney damage in rats journal of food and drug analysis 2017;25(4):890\u2013897.","DOI":"10.1016\/j.jfda.2017.05.001"},{"issue":"1","key":"2891_CR73","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1586\/egh.11.92","volume":"6","author":"F Tacke","year":"2012","unstructured":"Tacke F, Weiskirchen R. Update on hepatic stellate cells: pathogenic role in liver fibrosis and novel isolation techniques. Expert review of gastroenterology & hepatology. 2012;6(1):67\u201380.","journal-title":"Expert review of gastroenterology & hepatology"},{"key":"2891_CR74","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ultsonch.2015.12.004","volume":"31","author":"I Alzorqi","year":"2016","unstructured":"Alzorqi I, Ketabchi MR, Sudheer S, Manickam S. Optimization of ultrasound induced emulsification on the formulation of palm-olein based nanoemulsions for the incorporation of antioxidant \u03b2-d-glucan polysaccharides. Ultrason Sonochem. 2016;31:71\u201384.","journal-title":"Ultrason Sonochem"},{"issue":"2","key":"2891_CR75","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.jconrel.2006.02.014","volume":"112","author":"A Lamprecht","year":"2006","unstructured":"Lamprecht A, Benoit J-P. Etoposide nanocarriers suppress glioma cell growth by intracellular drug delivery and simultaneous P-glycoprotein inhibition. J Control Release. 2006;112(2):208\u201313.","journal-title":"J Control Release"},{"issue":"6","key":"2891_CR76","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s00535-016-1190-4","volume":"51","author":"T Greuter","year":"2016","unstructured":"Greuter T, Shah VH. Hepatic sinusoids in liver injury, inflammation, and fibrosis: new pathophysiological insights. J Gastroenterol. 2016;51(6):511\u20139.","journal-title":"J Gastroenterol"}],"updated-by":[{"DOI":"10.1007\/s11095-020-02944-3","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T00:00:00Z","timestamp":1601942400000}}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-020-02891-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11095-020-02891-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-020-02891-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T23:06:51Z","timestamp":1689203211000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11095-020-02891-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":76,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["2891"],"URL":"https:\/\/doi.org\/10.1007\/s11095-020-02891-z","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s11095-020-02944-3","asserted-by":"object"}]},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"26 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2020","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s11095-020-02944-3","URL":"https:\/\/doi.org\/10.1007\/s11095-020-02944-3","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors report no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"180"}}